Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?

After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?

  • August 14, 2026

Two recent patient deaths—both involving severe immune reactions to high-dose, viral vector-delivered gene therapies and a lack of disclosures—have drawn international scrutiny to what appear to be systemic gaps in oversight and transparency within China’s IIT framework.

Leave A Comment

Fields (*) Mark are Required